Zhao, W., Jiang, G., Bi, C., Li, Y., Liu, J., Ye, C., . . . Shao, R. (2015). The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation. Oncotarget.
Chicago Style CitationZhao, Wuli, et al. "The Dual Topoisomerase Inhibitor A35 Preferentially and Specially Targets Topoisomerase 2α By Enhancing Pre-strand and Post-strand Cleavage and Inhibiting DNA Religation." Oncotarget 2015.
Cita MLAZhao, Wuli, et al. "The Dual Topoisomerase Inhibitor A35 Preferentially and Specially Targets Topoisomerase 2α By Enhancing Pre-strand and Post-strand Cleavage and Inhibiting DNA Religation." Oncotarget 2015.
Atenció: Aquestes cites poden no estar 100% correctes.